MPWT
CHRS icon

MassMutual Private Wealth & Trust’s Coherus Oncology CHRS Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-70
Closed -$1K – 1671
2022
Q3 		$1K Buy
70
+47
+204% +$476 ﹤0.01% 1384
2022
Q2 		$0 Buy
+23
New +$200 ﹤0.01% 1539
2022
Q1 		– Sell
-35
Closed -$1K – 1524
2021
Q4 		$1K Buy
+35
New +$612 ﹤0.01% 1188

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MassMutual Private Wealth & Trust's CHRS Position: Q4 2022 in Review

MassMutual Private Wealth & Trust sold out of Coherus Oncology (CHRS) in Q4 2022, closing a stake of 70 shares — an estimated $1K sold.

MassMutual Private Wealth & Trust first reported a position in CHRS in Q4 2021 and held it in 3 quarters. The position peaked at $1K in Q3 2022. 161 funds tracked by Wall St. Rank hold CHRS as of Q4 2022.

  • MassMutual Private Wealth & Trust reported no remaining Coherus Oncology position as of Q4 2022 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 70 Coherus Oncology shares in Q4 2022, an estimated $1K.
  • MassMutual Private Wealth & Trust first reported a position in Coherus Oncology in Q4 2021 and held it in 3 quarters.
  • MassMutual Private Wealth & Trust's Coherus Oncology position peaked at $1K in Q3 2022.
  • 161 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2022.

Based on MassMutual Private Wealth & Trust's 13F filing for Q4 2022, filed 6 Jan 2023.